Page 54 - textbook5chapters
P. 54
1306 Technique of Intraperitoneal Chemotherapy: Normothermic and Hyperthermic
prospective randomized phase III study. Ann Surg Oncol. the treatment of advanced and recurrent ovarian cancer.
2015; 22(5):1570-1575. Gynecol Oncol 2015; 136:130-135
27. Pomel C, Ferron G, Lorimier G, et al. Hyperthermic intra- 40. https://clinicaltrials.gov/ct2/results?term=HIPEC+AND+
peritoneal chemotherapy using oxaliplatin as consolidation ovarian+cancer&Search=Search
therapy for advanced epithelial ovarian carcinoma. Results 41. Konate A, Poupon J, Villa A, et al. Evaluation of
of a phase II prospective multicentre trial. CHIPOVAC Environmental Contamination by Platinum and
study. Eur J Surg Oncol 2010; 36: 589-593. Exposure Risks for Healthcare Workers During a Heated
28. Helm CW, Bristow RE, Kusamura S, et al. Hyperthermic Intraperitoneal Perioperative Chemotherapy (HIPEC)
intraperitoneal chemotherapy with and without Procedure. J Surg Oncol 2011;103:86-89
cytoreductive surgery for epithelial ovarian cancer. J Surg 42. Ferron G, Simon L, Guyon F, et al. BIG-RENAPE Working
Oncol 2008; 98 (4):283-290. Group.Professional risks when carrying out cytoreductive
29. Huo YR, Richards A, Liauw W, et al., Hyperthermic surgery for peritoneal malignancy with hyperthermic
intraperitoneal chemotherapy (HIPEC) and cytoreductive intraperitoneal chemotherapy (HIPEC): A French
surgery (CRS) in ovarian cancer: A systematic review multicentric survey. Eur J Surg Oncol 2015;41(10):1361-
and meta-analysis, Eur J Surg Oncol 2015, http://dx.doi. 1367
org/10.1016/j.ejso.2015.08.172. Article in press 43. Glehen O, Cotte E, Kusamura S, et al. Hyperthermic
30. Bakrin N, Bereder JM, Decullier E, et al. Peritoneal intraperitoneal chemotherapy: nomenclature and
carcinomatosis treated with cytoreductive surgery and modalities of perfusion. J Surg Oncol 2008;98(4):242-246
hyperthermic intraperitoneal chemotherapy (HIPEC) 44. Esquivel J. Technology of Hyperthermic Intraperitoneal
for advanced ovarian carcinoma: a French multicentre Chemotherapy in the United States, Europe, China, Japan,
retrospective cohort study of 566 patients. Eur J Surg and Korea. Cancer J 2009; 15: 249-254.
Oncol 2013; 39: 1435–1443. 45. Ortega-Deballon P, Facy O, Jambet S, et al. Which Method
31. Classe JM, Glehen O, Decullier E, et al (French Oncologic to Deliver Hyperthermic Intraperitoneal Chemotherapy
and Gynecologic HIPEC Group). Cytoreductive Surgery with Oxaliplatin? An Experimental Comparison of Open
and Hyperthermic Intraperitoneal Chemotherapy for and Closed Techniques. Ann Surg Oncol 2010;17 (7):1957-
First Relapse of Ovarian Cancer. AntiCancer Res 2015; 1963
35(9):4997-5005. 46. Gesson-Paute A, Ferron G, Thomas F, et al.
32. Deraco M, Virzi S, Lusco D, et al. Secondary cytoreductive Pharmacokinetics of Oxaliplatin During Open Versus
surgery and hyperthermic intraperitoneal chemotherapy Laparoscopically Assisted Heated Intraoperative
for recurrent epithelial ovarian cancer: a multi-institutional Intraperitoneal Chemotherapy (HIPEC): An Experimental
study. BJOG 2012; 119 (7): 800-809. Study. Ann Surg Oncol 2008; 15 (1): 339-344
33. Safra T, Grisaru D, Inbar M, et al. Cytoreduction surgery 47. Sugarbaker PH, Averbach AM, Jacquet P, et al. A simplified
with hyperthermic intraperitoneal chemotherapy in approach to hyperthermic intraoperative intraperitoneal
recurrent ovarian cancer improves progression-free chemotherapy (HIIC) using a self retaining retractor.
survival, especially in BRCA-positive patients-A case- Cancer Treat Res 1996; 82: 415-421.
control study. J Surg Oncol 2014; 110:661–665. 48. Elias D, Antoun S, Goharin A, et al. Research on the best
34. Ceelen WP, Van Nieuwenhove Y, Van Belle S, et al. chemohyperthermia technique of treatment of peritoneal
Cytoreduction and hyperthermic intraperitoneal carcinomatosis after complete resection. Int J Surg Investig
chemoperfusion in women with heavily pretreated 2000;1: 431-439
recurrent ovarian cancer. Ann Surg Oncol 2012; 19:2352- 49. Makrin V, Lev-Chelouche D, Even Sapir E, et al.
2359. Intraperitoneal heated chemotherapy affects healing of
35. Gonzalez Bayon L, Steiner MA, Vasquez JW, et al. experimental colonic anastomosis: an animal study. J Surg
Cytoreductive surgery and hyperthermic intraperitoneal Oncol 2005; 89:18-22.
chemotherapy for the treatment of advanced epithelial 50. Chang E, Alexander HR, Libutti SK, et al. Laparoscopic
ovarian carcinoma: upfront therapy, at first recurrence, or continuous hyperthermic peritoneal perfusion. J Am Coll
later? Eur J Surg Oncol 2013; 39: 1109-1115. Surg 2001; 193: 225-229.
36. Cascales-Campos P, Gil J, Feliciangeli E, et al. The role 51. Facchiano E, Risio D, Kianmanesh R, et al. Laparoscopic
of hyperthermic intraperitoneal chemotherapy using Hyperthermic Intraperitoneal Chemotherapy: Indications,
paclitaxel in platinum sensitive recurrent epithelial ovarian Aims, and Results: A Systematic Review of the Literature.
cancer patients with microscopic residual disease after Ann Surg Oncol 2012;19(9):2946-50
cytoreduction. Ann Surg Oncol 2015; 22:987-993. 52. Valle SJ, Alzahrani NA, Alzahrani SE, et al. Laparoscopic
37. Barkin N, Classe JM, Pomel C, et al. Hyperthermic hyperthermic intraperitoneal chemotherapy (HIPEC)
intraperitoneal chemotherapy (HIPEC) in ovarian cancer. for refractory malignant ascites in patients unsuitable for
J Visc Surg 2014; 151: 347-353 cytoreductive surgery. Int J Surg. 2015 ;23:176-180
38. Roviello F, Roviello G, Petrioli R, et al. Hyperthermic 53. Fagotti A, Costantini B, Gallotta V, et al. Minimally Invasive
intraperitoneal chemotherapy for the treatment of ovarian Secondary Cytoreduction Plus HIPEC Versus Open
cancer: A brief overview of recent results. Crit Rev Oncol Surgery Plus HIPEC in Isolated Relapse From Ovarian
Hematol 2015; 95: 297-305 Cancer: A Retrospective Cohort Study on Perioperative
39. Chiva LM, Gonzalez-Martin A. A critical appraisal of Outcomes. J Min Invasive Gyn 2015; 22 (3): 428–432
hyperthermic intraperitoneal chemotherapy (HIPEC) in
